Geode Capital Management’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-412,218
| Closed | -$70K | – | 4884 |
|
|
2022
Q4 | $70K | Sell |
412,218
-23,428
| -5% | -$3.98K | ﹤0.01% | 4508 |
|
|
2022
Q3 | $188K | Hold |
435,646
| – | – | ﹤0.01% | 4250 |
|
|
2022
Q2 | $370K | Sell |
435,646
-334,990
| -43% | -$285K | ﹤0.01% | 3925 |
|
|
2022
Q1 | $4.25M | Buy |
770,636
+266
| +0% | +$1.47K | ﹤0.01% | 2891 |
|
|
2021
Q4 | $7.46M | Sell |
770,370
-29,138
| -4% | -$282K | ﹤0.01% | 2645 |
|
|
2021
Q3 | $14.3M | Sell |
799,508
-13,789
| -2% | -$247K | ﹤0.01% | 2196 |
|
|
2021
Q2 | $19.9M | Buy |
813,297
+94,744
| +13% | +$2.31M | ﹤0.01% | 1970 |
|
|
2021
Q1 | $19M | Buy |
718,553
+134,421
| +23% | +$3.56M | ﹤0.01% | 1913 |
|
|
2020
Q4 | $4.43M | Sell |
584,132
-22,483
| -4% | -$171K | ﹤0.01% | 2668 |
|
|
2020
Q3 | $3.04M | Buy |
606,615
+13,332
| +2% | +$66.8K | ﹤0.01% | 2662 |
|
|
2020
Q2 | $3.55M | Buy |
593,283
+42,122
| +8% | +$252K | ﹤0.01% | 2519 |
|
|
2020
Q1 | $2.45M | Buy |
551,161
+38,291
| +7% | +$170K | ﹤0.01% | 2568 |
|
|
2019
Q4 | $4.87M | Buy |
512,870
+21,000
| +4% | +$199K | ﹤0.01% | 2473 |
|
|
2019
Q3 | $3.86M | Buy |
491,870
+156,230
| +47% | +$1.23M | ﹤0.01% | 2538 |
|
|
2019
Q2 | $5.28M | Buy |
335,640
+31,016
| +10% | +$488K | ﹤0.01% | 2350 |
|
|
2019
Q1 | $5.51M | Buy |
304,624
+106,087
| +53% | +$1.92M | ﹤0.01% | 2272 |
|
|
2018
Q4 | $3.19M | Buy |
198,537
+36,692
| +23% | +$590K | ﹤0.01% | 2496 |
|
|
2018
Q3 | $3.88M | Buy |
+161,845
| New | +$3.88M | ﹤0.01% | 2519 |
|